CREDIT SUISSE AG/ - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$333,8750.0%360,0000.0%0.00%
Q1 2023$333,875
-84.9%
360,000
-84.7%
0.00%
-100.0%
Q3 2022$2,216,000
+24522.2%
2,350,000
+23400.0%
0.00%
Q2 2022$9,000
-35.7%
10,000
-33.3%
0.00%
Q3 2021$14,000
-99.7%
15,000
-99.7%
0.00%
-100.0%
Q2 2021$4,385,000
+974.8%
4,761,000
+1090.2%
0.00%
Q4 2020$408,000400,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 2,756,000$2,621,7832.46%
Sonora Investment Management Group, LLC 18,573,000$17,727,7271.52%
PALISADE CAPITAL MANAGEMENT, LP 2,614,000$2,483,3000.07%
Kohlberg Kravis Roberts & Co. L.P. 510,000$487,7130.02%
PINNACLE ASSOCIATES LTD 280,000$267,1540.01%
MACQUARIE GROUP LTD 3,903,000$3,732,0000.01%
HighTower Advisors, LLC 2,453,000$2,355,0000.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 2,500,000$2,357,5000.00%
CITIGROUP INC 1,754,000$1,668,5800.00%
MORGAN STANLEY 7,090,000$6,717,7750.00%
View complete list of IONIS PHARMACEUTICALS INC shareholders